Skip to content
Open access

NE13 Neuropsychiatric disturbances in patients with Cushing’s syndrome are highly prevalent and may represent the initial manifestation of the disease: The ERCUSYN Krakow Database

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

Three cases of life-threatening psychiatric disturbances constituting the first clinical CS manifestation are presented and further studies are needed to understand underlying pathophysiological mechanisms, explain inter-etiological differences and evaluate the extent of post-treatment symptom reversibility.

Abstract

Neuropsychiatric symptoms are frequently observed in patients with Cushing’s syndrome (CS), yet their characteristics have not been thoroughly investigated. Common manifestations include depression, anxiety, insomnia, mania, psychosis, and cognitive impairment. This study aimed to characterize neuropsychiatric profiles of patients with CS across different etiologies. A retrospective analysis was performed in 238 patients with CS included in the Krakow cohort of the ERCUSYN database: pituitary (PIT-CS-53%), adrenal (ADR-CS-25%), and ectopic (ECT-CS-22%). Data regarding the occurrence of depression, anxiety disorders, insomnia, mania, psychosis, cognitive impairment, intellectual disability, and suicide attempts were extracted from medical records. Inter-etiological differences were assessed using chi-square test followed by post-hoc pairwise comparisons with Holm–Bonferroni correction (IBM SPSS Statistics 31.0.1.0). Overall, 73% of patients experienced baseline neuropsychiatric symptoms attributable to CS, most commonly insomnia(63%), depression(49%) and anxiety(34%). Other clinically significant presentations included psychosis(7%), mania(3%) and suicidal tendencies(1%). Furthermore, 54% of patients exhibited cognitive decline. In 11% CS diagnosis was preceded with psychiatric treatment. A significantly higher prevalence of anxiety disorders was observed in patients with PIT-CS compared with ADR-CS (34%vs.22%, p=0.005). Psychosis was significantly more frequent in ECT-CS than in PIT-CS (14%vs.6%, p=0.004) and ADR-CS(14%vs.2%, p=0.017). We additionally present three cases of life-threatening psychiatric disturbances constituting the first clinical CS manifestation. Neuropsychiatric disturbances affect most patients with CS and may be initial hypercortisolism manifestation. Increased awareness of such symptoms may accelerate CS diagnosis. Further studies are needed to understand underlying pathophysiological mechanisms, explain inter-etiological differences and evaluate the extent of post-treatment symptom reversibility.

Read PDF

Similar papers

Sep 2026

Prevalence of Mental Disorders and its Severity among Patients with Polycystic Ovarian Disease-Observational Cross-Sectional Study

A high prevalence and severity of depression and anxiety in PCOD patients indicates this condition warrants a multidisciplinary approach towards treatment; involving both a psychiatrist and a gynecologist will be helpful to the patient.

Seetesh Ghose · 0 citations
Review Open access Sep 2026

CUSHING SYNDROME – DISEASE OF BOTH BODY AND MIND. LITERATURE REVIEW

Current state of knowledge on clinical features of Cushing Syndrome is presented to understand the course of CS and potential long-term consequences of the disease.

Klaudia Gogół-Fijał, Zuzanna Michalik, Klaudia Kapelka et al. · 0 citations
Open access Sep 2026

Clinical Factors Associated with Anxiety Disorders in Adults with Childhood Hypospadias Repair: Results from the F.R.E.S.H. Study

Objectives: This study aimed to evaluate the prevalence of pathological anxiety and to identify clinical, functional, and surgical factors associated with anxiety disorders in adults who underwent hypospadias repair during childhood. Patients and Methods: This cross-sectional analysis included adult males (≥18 years) p...

M. Gnech, M. Buoli, F. Fanti et al. · 0 citations
Sep 2026

Disorders of Gut-Brain Interaction in Juvenile Fibromyalgia Syndrome: Prevalence, Clinical Characteristics, and Management in a Single-Centre Cohort Study.

DGBI are very common in JFS and may significantly affect patients' functional capacity and are associated with more severe and widespread musculoskeletal pain, underscoring the importance of a multidisciplinary approach in the management of JFS.

S. Ancona, A. Ronchetti, Elena Pescio et al. · 0 citations
Review Sep 2026

Approach to the Patient: Diagnosis and Management of Cushing's Syndrome in the Elderly - How Different Is It?

A practical approach begins by excluding exogenous glucocorticoid exposure, identifying progressive and discriminatory features, and selecting screening tests that account for renal function, sleep pattern, drug interactions, and the probability of non-neoplastic hypercortisolism.

Yu-Ke Liu, Ling Yi, Hui-Wen Tan · 0 citations
Open access Aug 2026

Inflammation and neuropsychiatric symptoms in Parkinson's disease: a genetic association

Background There has been some evidence that neuroinflammation is involved in Parkinson's disease (PD) and in psychiatric disorders. Objective To explore the effects of IL-1β rs16944 on PD patients' neuropsychiatric symptoms. Methods Two hundred and eighty-one consecutive PD patients underwent a neurological and neurop...

A. Gonçalves, Alexandre Mendes, J. Damásio et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.